Debra L. Laskin

Debra L. Laskin, Ph.D.

Vesicant-induced Pulmonary Injury
Distinguished Professor & Chair, Pharmacology & Toxicology, Ernest Mario School of Pharmacy, Rutgers University

[Link to Bio] [Back to Members Page]

Recent Publications

More Publications

Jump to…

Jeffrey D. Laskin
Donald R. Gerecke
Debra L. Laskin
Marion K. Gordon
Patrick Sinko
Diane E. Heck
Ned D. Heindel
Joshua P. Gray
Robert P. Casillas
Clifton R. Lacy
Hong Duck Kim
Jules Mitchel
Lauren Aleksunes
Carol Gardner
Laurie Joseph
Raymond Rancourt

Our Center
The National Institutes of Health has awarded a grant to Rutgers University to support a Center of Excellence focused on the development of new and improved medical countermeasures against high priority chemical threats. The Rutgers University CounterACT Research Center of Excellence is focused on developing drugs to treat vesicant poisoning. Read more…

Message from the Director
“This is a massive effort designed to coordinate many different research groups. We will develop drugs that can be used against actual chemicals that could be used in a terror attack.”
— Jeffrey D. Laskin, Ph.D. – Center Director

About Us

The Rutgers University CounterACT Research Center of Excellence is a collaboration between Rutgers University, New York Medical College, Lehigh University, United States Coast Guard Academy, MRIGlobal, and Target Health Inc.